Product Images Duloxetine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Duloxetine NDC 55700-605 by Quality Care Products Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - New Doc 2018 04 18 1

image description - New Doc 2018 04 18 1

This is a box of Duloxetine DR 30mg capsules. The recommended storage temperature is between 53-86 degrees F. It is important to keep this medication out of reach of children. The box contains 30 capsules, and the GTIN number is 00355700605308. The NDC number is 55700-0605-30. The manufacturer is Ajanta Pharma Limited, located in Paithan 431 148, India. There is a warning to consult with a physician or see an insert for dosage information. The text also includes a serial number, lot number, and expiration date, but they are not legible due to the quality of the .*

figure01 - duloxetine fig01

figure01 - duloxetine fig01

This is a graph showing the proportion of patients with relapse for a certain treatment (placebo or duloxetine) over time (measured in days). The X-axis shows the time from randomization to relapse while the Y-axis shows the proportion of patients with relapse. The graph indicates that the treatment with duloxetine was associated with fewer relapses compared to placebo.*

figure2 - duloxetine fig02

figure2 - duloxetine fig02

The text represents a graph that shows the proportion of patients with relapse over time after treatment with a placebo or duloxetine. The x-axis represents the time from randomization to relapse in days, while the y-axis shows the proportion of patients. The graph indicates that fewer patients relapsed with duloxetine compared to the placebo, suggesting that duloxetine may be an effective treatment for preventing relapse.*

figure04 - duloxetine fig04

figure04 - duloxetine fig04

figure07 - duloxetine fig07

figure07 - duloxetine fig07

This text appears to be a chart or graph displaying the effectiveness of the drug Placebo in comparison to Duloxetine at doses of 60/120 mg taken once daily. It appears to show the percentage improvement in pain from baseline using a BOCF measurement. The meaning of the symbols (letters, numbers, and shapes) in the graph is not clear, so no additional information can be provided.*

figure08 - duloxetine fig08

figure08 - duloxetine fig08

This appears to be a graph displaying the percent improvement in pain from baseline (BOCF) between a placebo and the drug Duloxetine (at a 60 mg daily dose). The numbers on the x-axis appear to represent different time intervals. There is no further information available to determine the context of the study or the purpose of the graph.*

figure09 - duloxetine fig09

figure09 - duloxetine fig09

The text describes the use of Duloxetine at a dose of 60-120mg once daily for the treatment of pain. It also includes a chart showing the percent improvement in pain from baseline.*

duloxetine-structure - duloxetine structure

duloxetine-structure - duloxetine structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.